Insomnia is a disorder of initiating sleep, maintaining sleep, or experiencing nonrestorative sleep, occurring despite adequate opportunity to sleep, with associated daytime impairment. Clinically, it is characterized by dissatisfaction with sleep quality and/or difficulty sleeping at least three nights per week, for at least three months, as reflected in diagnostic criteria used in practice. Insomnia can be acute (short duration) or chronic, and it may be primary or comorbid with conditions such as mood disorders, anxiety disorders, chronic pain, sleep apnea, restless legs syndrome, and substance or medication effects. The neurobiology involves dysregulation of arousal systems, including hyperactivity of the hypothalamic-pituitary-adrenal axis and altered balance among wake-promoting and sleep-promoting neural circuits. At the cognitive level, insomnia is often maintained by maladaptive beliefs about sleep and conditioned arousal, where attempts to sleep lead to increased vigilance and anxiety.
A central mechanism is cognitive and physiological hyperarousal. People with insomnia frequently experience elevated cognitive activation—rumination, threat monitoring, and worry about consequences of poor sleep—alongside physiological changes such as increased sympathetic tone, cortical arousal, and difficulty downshifting from wakefulness to sleep. In chronic insomnia, learned associations can develop: the bed and bedroom become cues for wakefulness rather than sleep. This conditioning is reinforced by behaviors that inadvertently increase arousal (e.g., lying awake for extended periods, checking the time, using the bed for activities other than sleep or sex). Circadian misalignment can further worsen insomnia by shifting sleep propensity to an incompatible time, especially in individuals with irregular schedules, shift work, or inconsistent light exposure.
Treatment is most effective when targeted to perpetuating factors. Sleep hygiene education is often a starting point but is not sufficient alone for many patients with chronic insomnia. Key components include maintaining a consistent sleep-wake schedule, limiting time in bed when awake, reducing caffeine and nicotine close to bedtime, moderating alcohol intake (which can fragment sleep), and ensuring a dark, cool, quiet environment. Light exposure is a powerful zeitgeber: bright light in the morning can advance circadian phase, while reducing bright light at night (including from screens) can facilitate melatonin signaling. However, behavioral strategies addressing maladaptive arousal are typically required.
The first-line behavioral treatment for chronic insomnia is Cognitive Behavioral Therapy for Insomnia (CBT-I). CBT-I integrates multiple techniques: stimulus control (reassociating the bed with sleep by using it only when sleepy and leaving the bed if unable to sleep within a set interval), sleep restriction therapy (consolidating sleep by limiting time in bed to match estimated sleep duration, then gradually expanding as sleep improves), cognitive restructuring (challenging catastrophic beliefs about insomnia and focusing on controllable factors), and relaxation training (progressive muscle relaxation, diaphragmatic breathing, or guided imagery). CBT-I improves sleep latency, wake time after sleep onset, and overall sleep quality with durable benefits relative to many pharmacologic options.
Pharmacotherapy may be considered for short-term management or as an adjunct while CBT-I is initiated, particularly when symptoms are severe. Options can include nonbenzodiazepine hypnotics, benzodiazepines, orexin receptor antagonists, melatonin receptor agonists, and certain antidepressants used off-label depending on comorbidities and risk profiles. Medication selection should account for age-related fall risk, respiratory considerations, tolerance, dependence potential, next-day impairment, drug-drug interactions, and the possibility of underlying sleep disorders such as obstructive sleep apnea. Long-term reliance on sedative-hypnotics is generally discouraged without concurrent behavioral intervention because of diminishing efficacy and adverse effects.
When insomnia is secondary to another condition, addressing the underlying driver is crucial. For example, treating depression or anxiety, optimizing pain control, managing reflux, evaluating for sleep-disordered breathing, and screening for restless legs syndrome can substantially improve sleep outcomes. Clinicians also recommend reviewing substances and medications, including stimulants, corticosteroids, decongestants, and certain antidepressants or antipsychotics that may affect sleep architecture.
In many cases, patients benefit from wind-down routines that reduce arousal. Relaxation and structured attention strategies can help shift cognitive activation away from worry. Auditory non-demanding stimuli—such as a calming or engaging audiobook—can function as an attentional anchor, potentially lowering perceived arousal and helping some individuals fall asleep faster. While such approaches are not substitutes for CBT-I, they can support behavioral sleep goals by reducing time spent awake in bed and discouraging clock-watching.
In summary, insomnia reflects a multifactorial disturbance involving hyperarousal, cognitive conditioning, and circadian factors, often maintained by maladaptive behaviors and beliefs. Evidence-based care centers on CBT-I, supplemented by targeted sleep hygiene, circadian light management, appropriate evaluation for comorbid sleep or medical conditions, and judicious use of medication when indicated. Source: Josh Lanyon (social post encouraging help for insomnia via audiobooks).
Josh Lanyon: 🐑 👀Can’t Sleep? 🕰️💤Try an audiobook! Action. Adventure. Romance. Funny ax murders. 😉 All your favorite stories and all you have to do is keep your ears open! #LGBTaudio #gaymystery #mmromance. #breaking
— @JoshLanyon May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
